CONMED Corp. Given New $40.00 Price Target at Needham & Company (CNMD)
Analysts at Needham & Company hoisted their price target on shares of CONMED Corp. (NASDAQ:CNMD) from $37.00 to $40.00 in a research report issued to clients and investors on Friday, American Banking and Market News reports. The firm currently has a “buy” rating on the stock. Needham & Company’s price target points to a potential upside of 9.17% from the stock’s previous close.
CONMED Corp. (NASDAQ:CNMD) traded up 0.08% during mid-day trading on Friday, hitting $36.64. The stock had a trading volume of 63,324 shares. CONMED Corp. has a 52 week low of $25.39 and a 52 week high of $34.86. The stock has a 50-day moving average of $32.35 and a 200-day moving average of $32.38. The company has a market cap of $1.007 billion and a P/E ratio of 25.96.
CONMED Corp. (NASDAQ:CNMD) last released its earnings data on Thursday, October 24th. The company reported $0.40 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.40. The company had revenue of $179.30 million for the quarter, compared to the consensus estimate of $186.20 million. During the same quarter in the prior year, the company posted $0.43 earnings per share. The company’s quarterly revenue was down 1.4% on a year-over-year basis. On average, analysts predict that CONMED Corp. will post $1.80 earnings per share for the current fiscal year.
CONMED Corporation (NASDAQ:CNMD) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.